←Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Brain Metastasis
F Stephen Hodi
MD
🏢Dana-Farber Cancer Institute🌐USA
Director, Melanoma Disease Center
120
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
F Stephen Hodi led the pivotal trials that established ipilimumab in melanoma and has contributed extensively to combination immunotherapy including for brain metastases. His work spans biomarker discovery and novel combinations. He is a foundational figure in cancer immunotherapy.
Share:
🧪Research Fields 研究领域
melanoma
ipilimumab
immunotherapy
brain metastasis
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 F Stephen Hodi 的研究动态
Follow F Stephen Hodi's research updates
留下邮箱，当我们发布与 F Stephen Hodi（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment